STANSBERRY ASSET MANAGEMENT, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
STANSBERRY ASSET MANAGEMENT, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$753,000
-23.1%
73,808
-2.0%
0.25%
-48.2%
Q1 2018$979,000
-23.8%
75,339
+4.9%
0.48%
-13.0%
Q4 2017$1,285,00071,8020.55%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders